Literature DB >> 29623393

Differences in laser lead extraction of infected vs. non-infected leads.

Simon Pecha1, Liesa Castro2, Julia Vogler3, Matthias Linder2, Nils Gosau3, Stephan Willems3, Hermann Reichenspurner2, Samer Hakmi2.   

Abstract

We investigated the effect of systemic infection or lead endocarditis on the complexity and the success of laser lead extraction (LLE) procedures. Medical records of all patients undergoing LLE between January 2012 and March 2017 were screened with regard to information on systemic infection or lead endocarditis. We treated 184 patients using high-frequency 80 Hz laser sheaths in patients with lead implant duration of ≥ 12 months. Indications for lead extraction were systemic infection and lead endocarditis in 52 cases (28.3%), local infection in 74 cases (40.2%), lead dysfunction in 37 cases (20.1%) and other indications in 21 cases (11.4%). 386 leads were scheduled for LLE: 235 (60.9%) pacing, 105 (27.2%) ICD and 46 (11.9%) CS leads. The mean time from initial lead implantation (systemic infection 96.8 ± 74.7 months vs. 102.1 ± 82.6 non-infected: months; p = 0.4155) and ratio of ICD leads (26.8 vs. 27.4%; p = 0.3411) did not differ significantly between the two groups. Complete procedural success was significantly higher in the systemic infection group (100 vs. 94.7%; p = 0.0077). The mean laser treatment (60.2 ± 48.7 vs. 72.4 ± 61.5 s; p = 0.2038) was numerically lower in the infection group, while fluoroscopy time (9.3 ± 7.6 vs. 12.8 ± 10.3 min; p = 0.0275) was significantly lower in this group. Minor and major complications were low in both groups and did not reveal any statistically significant difference (infected group: one minor complication; pocket hematoma, non-infected: three major complications; emergent sternotomy due to pericardial tamponade). No extraction related mortality was observed. The presence of systemic infection or lead endocarditis in LLE procedures allows for higher complete procedural success. When compared with LLE of non-infected leads, the infected leads require less laser and fluoroscopy times. Due to the scarcity of minor and major complications in general, no statistical significance was found in that regard.

Entities:  

Keywords:  CIED infections; Laser lead extraction; Lead endocarditis; Pacemaker infection

Mesh:

Year:  2018        PMID: 29623393     DOI: 10.1007/s00380-018-1162-0

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  21 in total

1.  Morphologic and immunohistochemical observations of tissues surrounding retrieved transvenous pacemaker leads.

Authors:  Marco Esposito; Charles Kennergren; Nils Holmström; Susanne Nilsson; Johan Eckerdal; Peter Thomsen
Journal:  J Biomed Mater Res       Date:  2002

2.  A historical perspective of pacemaker infections: 40-years single-centre experience.

Authors:  Tina S Tischer; Anne Hollstein; Wolfgang Voss; Imke Wendig; Jörg Lauschke; Ralph Schneider; Georg H von Knorre; Dietmar Bänsch
Journal:  Europace       Date:  2013-06-28       Impact factor: 5.214

Review 3.  2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.

Authors:  Fred M Kusumoto; Mark H Schoenfeld; Bruce L Wilkoff; Charles I Berul; Ulrika M Birgersdotter-Green; Roger Carrillo; Yong-Mei Cha; Jude Clancy; Jean-Claude Deharo; Kenneth A Ellenbogen; Derek Exner; Ayman A Hussein; Charles Kennergren; Andrew Krahn; Richard Lee; Charles J Love; Ruth A Madden; Hector Alfredo Mazzetti; JoEllyn Carol Moore; Jeffrey Parsonnet; Kristen K Patton; Marc A Rozner; Kimberly A Selzman; Morio Shoda; Komandoor Srivathsan; Neil F Strathmore; Charles D Swerdlow; Christine Tompkins; Oussama Wazni
Journal:  Heart Rhythm       Date:  2017-09-15       Impact factor: 6.343

4.  Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections.

Authors:  Katherine Y Le; Muhammad R Sohail; Paul A Friedman; Daniel Z Uslan; Stephen S Cha; David L Hayes; Walter R Wilson; James M Steckelberg; Larry M Baddour
Journal:  Heart Rhythm       Date:  2011-05-27       Impact factor: 6.343

5.  Intravascular extraction of problematic or infected permanent pacemaker leads: 1994-1996. U.S. Extraction Database, MED Institute.

Authors:  C L Byrd; B L Wilkoff; C J Love; T D Sellers; K T Turk; R Reeves; R Young; B Crevey; S P Kutalek; R Freedman; R Friedman; J Trantham; M Watts; J Schutzman; J Oren; J Wilson; F Gold; N E Fearnot; H J Van Zandt
Journal:  Pacing Clin Electrophysiol       Date:  1999-09       Impact factor: 1.976

6.  Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association.

Authors:  M J Pekka Raatikainen; David O Arnar; Katja Zeppenfeld; Jose Luis Merino; Francisco Levya; Gerhardt Hindriks; Karl-Heinz Kuck
Journal:  Europace       Date:  2015-01       Impact factor: 5.214

7.  Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infections.

Authors:  Federico Viganego; Susan O'Donoghue; Zayd Eldadah; Manish H Shah; Mohit Rastogi; Jay A Mazel; Edward V Platia
Journal:  Am J Cardiol       Date:  2012-02-21       Impact factor: 2.778

8.  Extraction of pacemaker and implantable cardioverter defibrillator leads: patient and lead characteristics in relation to the requirement of extraction tools.

Authors:  Frank Bracke; Albert Meijer; Berry Van Gelder
Journal:  Pacing Clin Electrophysiol       Date:  2002-07       Impact factor: 1.976

9.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Authors:  Larry M Baddour; Andrew E Epstein; Christopher C Erickson; Bradley P Knight; Matthew E Levison; Peter B Lockhart; Frederick A Masoudi; Eric J Okum; Walter R Wilson; Lee B Beerman; Ann F Bolger; N A Mark Estes; Michael Gewitz; Jane W Newburger; Eleanor B Schron; Kathryn A Taubert
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

10.  Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.

Authors:  Cengiz Özcan; Jakob Raunsø; Morten Lamberts; Lars Køber; Tommi Bo Lindhardt; Niels Eske Bruun; Marie Louise Laursen; Christian Torp-Pedersen; Gunnar Hilmar Gislason; Morten Lock Hansen
Journal:  Europace       Date:  2017-06-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.